Literature DB >> 25870748

Identification and characterization of class 1 integrons among atypical enteropathogenic Escherichia coli isolated from children under 5 years of age.

Farzad Shahcheraghi1, Fatemeh Rahmati Ghezelgeh2, Saman Nobari2, Elham Torabi2, Seyed Fazlollah Mousavi2, Mohammad Mehdi Aslani2, Fereshteh Shahcheraghi2.   

Abstract

BACKGROUND AND OBJECTIVES: The therapeutic options for diseases caused by Escherichia coli are limited. In this study we investigated the presence of virulence factors among Enteropathogenic Escherichia coli (EPEC) strains and their antibiotic resistance patterns. The isolates were also checked for the presence of class1 integrons and gene cassettes.
MATERIALS AND METHODS: This study included 70 EPEC strains isolated from children. Antimicrobial resistance patterns were determined using diffusion methods. The broth microdilution methods was used to determine the minimum inhibitory concentration. PCR was used to detect eaeA, bfpA genes. The 5' and 3' conserved sequences (CSs) of class 1 integrons and intI gene were amplified to investigate the presence of integrons and gene cassettes.
RESULTS: Antimicrobial susceptibility testing showed that 4 (5.7%), 3 (4.2%), and 2 (2.8 %) isolates were resistant to ampicillin, trimethoprim-sulfamethoxazole, and ceftazidime, respectively. Resistance rates to ciprofloxacin and aztreonam were 1.4%. Thirteen (18.5%) isolates showed resistance to tetracycline, and 4 (5.7%) were kanamycin resistant. Class I integron detected in 22 (31.4%) isolates. All the gene cassettes found in class I integrons corresponded to different variants of dfr and aadA genes.
CONCLUSION: Prevalence of class I integrons in EPEC strains was high. Presence of aadA and dfr gene cassettes in integrons represents high distribution of resistance determinants in EPEC strains.

Entities:  

Keywords:  Children; Class I integrons; Enteropathogenic Escherichia coli

Year:  2014        PMID: 25870748      PMCID: PMC4393491     

Source DB:  PubMed          Journal:  Iran J Microbiol        ISSN: 2008-3289


INTRODUCTION

Diarrhea remains one of the major causes of morbidity and mortality among children worldwide (1). Enteropathogenic Escherichia coli (EPEC) is the predominant cause of diarrhea in infant worldwide and represents an important endemic health threat to children under 5 years of age in developing countries (2). Approximately 30-40% of infant diarrhea is caused by EPEC (3). In Iran, EPEC strains were isolated from 44.9% of the children with diarrhea (4). These strains posses a number of virulence factors and a virulence plasmid that are responsible for infections caused by EPEC, although they cannot produce classic toxins (5). EPEC is classified into two groups: Typical EPEC (tEPEC), and atypical EPEC (aEPEC). The main virulence mechanism of EPEC is localized adherence to the host gut epithelium by inducing of a specific lesion on enterocytes, which called attaching-effacing (A/E) lesion. The locus of enterocyte effacement (LEE) encoded adhesion determine establishment of A/E lesions. LEE is a chromosomal pathogenicity island, which is present in both EPEC subgroups (6). Recently, therapeutic options for diseases caused by E. coli are limited because of the emergence and spread of Extended Spectrum ß-lactamases (ESBL), and increasing of multiple drug resistant strains (7). The carbapenems are sometimes the only effective options against resistant strains. However, recent studies reported carbapenems resistance in clinical isolates of E. coli, which is a major cause for concern in treatment of both intestinal and urinary tract infections (8, 9). Integrons play a major role in the antimicrobial resistance of clinical isolates because they are genetic elements capable to capture, integrate and express antimicrobial resistance gene cassettes (10). The efficacy of integrons in distribution of antimicrobial resistance in clinical isolates of E. coli has been well documented (11, 12). In this study, we investigated the prevalence of EPEC among Iranian children and study their resistance patterns and presence of class1 integrons in EPEC strains.

MATERIAL & METHODS

Bacterial strains and identification methods

This study included 70 EPEC strains isolated from children less than 5 years of age with and without diarrhea in Tehran hospitals from May 2010 to July 2012. All isolates were identified using standard microbiological methods (4).

Identification of eaeA and bfpA gene

DNA of bacterial isolates was extracted as described previously (13). All isolates were tested by PCR to detect eaeA and bfpA gene in EPEC strains. Primers and PCR conditions used in this study are listed in Table 1.
Table 1

Oligonucleotide primers used in this study.

PrimerTarget gene/regionSequence (5’-3’)Product size (bp)Annealing temp (°C)Reference
BFP-F
bfpAAATGGTGCTTGCGCTTGCTGC
3265636
BFP-RGCCGCTTTATCCAACCTGGTA

EAE-F
eaeACATTATGGAACGGCAGAGGT
7905537
EAE-RATCTTCTGCGTACTGCGTTCA

CS-F
5 CSGGCATCCAAGCAGCAAG
Variable5438
CS-R3 CSAAGCAGACTTGACCTGA

Int-F
intIGCCTTGCTGTTCTTCTACGG
5585639
Int-RGATGCCTGCTTGTTCTACGG

SUL-F
sul-1CTTCGATGAGAGCCGGCGGC
4376838
SUL-RGCAAGGCGGAAACCCGCGCC

qac-F
qacEΔ1ATCGCAATAGTTGGCGAAG
2405439
qac-RCAAGCTTTTGCCCATGAAGC

Serogrouping of EPEC Strains

Determination of EPEC serogroups was performed by slide agglutination method with O-specific antisera according to the instructions recommended by manufacturer (Bio-Rad, France).

Antimicrobial Susceptibility testing

Antimicrobial susceptibility pattern of strains was determined by disk diffusion method, according to the Clinical Laboratory Standard Institute (CLSI) criteria (14). The following antimicrobial discs were examined: ampicillin (30 μg/ml), aztreonam (30 μg/ml), cefotaxime (30 μg/ml), cefepime (30 μg/ml), ceftazidime (30 μg/ml), ciprofloxacin (5 μg/ml), gentamicin (10 μg/ml), amikacin (30 μg/ml), kanamycin (30 μg/ml), tetracycline (30 μg/ml), chloramphenicole (30 μg/ml), nalidixic acid (30 μg/ml), and trimethoprime-sulfamethoxazole (15 μg/ml) (MAST diagnostics, Bostle, Mersey side). In addition, Minimum Inhibitory Concentration (MIC) of kanamycin and tetracycline were determined using broth microdilution as methods recommended by CLSI guidelines (15). E. coli ATCC 25922 was used as a susceptible control strain in all antimicrobial tasting. Multidrug resistance was defined as resistance to three or more of different antimicrobial classes.

Detection and characterization of Integrons and associated gene cassette

Class 1 integrons and associated sulfonamide resistance gene (sul1), and int1 region of the integrase gene were identified by PCR using primers and PCR conditions listed in Table1. Gene cassette assortments in class 1 integrons were detected by PCR using 5’ and 3’ CS primers. The PCR products were sequenced in both directions. Sequences were analyzed via the BLAST and MEGA programmers.

Nucleotide sequence accession numbers

The nucleotide sequences of gene cassettes reported in this study have been submitted to GenBank under accession numbers JX442969-72.

RESULTS

All isolates were confirmed as E. coli using routine biochemical identification methods. Presence of eaeA gene was confirmed in all 70 strains isolated from diarrhea children. Two isolates (2.85%) had both virulence factors (eaeA, bfpA) and classified as typical EPEC. However, bfpA gene was not found in 68 (97.14%) isolates. These isolates (eaeA%, bfpA-) classified as atypical EPEC. H typing of EPEC strains showed 15 different H types. H21 was the most prevalent (8.5%) among EPEC strains isolated from children, followed by H2 (5.7%) and H48 (4.2%). Resistance to tetracycline (18.5%), ampicillin (5.7%), kanamycin (5.7%), and trimethoprim-sulfamethoxazole (4.2%) was remarkable. However, all isolates were susceptible to gentamicin and cefepime (Table2). Determination of MICs to tetracycline and kanamycin showed that 13 (18.5%) isolates were tetracycline resistant (MIC≥16 μg/ml) and 4 (5.7%) isolates were kanamycin resistant (MIC≥ 64 μg/ml). Four (5.7%) strains were multidrug resistant (resistance to three or more antimicrobial classes). Class I integron containing int1, qacΔE, and sul1 were detected in 22 (31.4%) of strains (Fig.1, Table 3).
Table 2

Antimicrobial susceptibility patterns of EPEC strains.

AntibioticsResistanceIntermediateSusceptible
Gentamicin0(0%)2(2.18%)68(97.1%)
Kanamycin4(5.7%)19(27.1%)47(67.1%)
Tetracycline13(18.5%)16(22.8%)41(58.5%)
Ciprofloxacin1(1.4%)0(0%)69(98.5%)
Nalidixic Acid1(1.4%)3(4.2%)66(94.2%)
Chloramphenicole2(2.8%)3(4.2%)65(92.8%)
Trimethoprime-sulfamethoxazole3(4.2%)1(1.4%)66(94.2%)
Ceftazidime2(2.8%)2(2.8%)66(94.2%)
Cefotaxime0(0%)1(1.4%)69(98.5%)
Aztreonam1(1.4%)0(0%)69(98.5%)
Amikacin2(2.8%)0(0%)68(97.1%)
Ampicillin4(5.7%)0(0%)66(94.2%)
Cefepime0(0%)0(0%)70(100%)
Fig 1

Detection of intI gene among nine EPEC strains. Lane M, 100 bp ladder; Lane 1, Positive control strain; Lanes 2 to 10, EPEC strains isolated in this study; Lane N, negative control (E.coli ATCC 25922).

Table 3

Characterization of Class1 integrons and gene cassttes in 22 Enteropathogenic Escherichia coli (EPEC).

STRAINSSerogroupH TypeEPEC TypeintI1qac% sul1Size of gene cassettes (bp)Identified gene Cassettes
16O111H4atypic++1800aadA1, dfrA1
17bO111NTaatypic++2000aadA2, dfrA12, orfF
18bO111H21atypic++2000aadA2, dfrA12, orfF
19bO111NTatypic++1800aadA1, dfrA1
20O111H36atypic++1800aadA1, dfrA1
27O111H15atypic++1800aadA1, dfrA1
28O111H27typic++1800aadA1, dfrA1
29O111H31atypic++1800aadA1, dfrA1
30O111H27atypic++1800aadA1, dfrA1
34O111H21atypic++1800aadA1, dfrA1
35O111H2atypic++1800aadA1, dfrA1
39O111H3atypic++800dfrVII
40O111H20atypic++800dfrVII
48O111H14atypic++800dfrVII
78O111NTatypic++1800aadA1, dfrA1
80O127NTatypic++1800aadA1, dfrA1
82O127NTatypic++1800aadA1, dfrA1
91O55H48atypic++800dfrVII
187O142H21atypic++1500drfA1, orfC
190O142H2atypic++800dfrVII
386NTNTatypic++1500drfA1, orfC
1719bNTH48atypic++1500drfA1, orfC

NT, Non Typable

Multidrug resistance strains (resistance to three or more of different antimicrobial classes).

Following PCR amplification of variable region of class 1 integrons, 4 different groups of gene cassette were detected. Groups 1, 2, 3, and 4 included fragments with 2000, 1800, 1500, and 800 bp size, respectively. Characterization of these gene cassettes by sequencing demonstrated different variants of aadA (aadA1, aadA2) and dfr genes (dfrA1, dfr7, dfrA12). Group 1 consisted from two isolates. Three gene cassettes (dfrA12, orfF, and aadA2) were shown in these isolates following sequencing. Twelve isolates with dfrA1 and aadA1, classified in group 2. Group 3 included dfrA1 and orfC gene cassettes that three isolates belonged to this group. Finally five isolates classified in group 4 and were contained dfr7.

DISCUSSION

Enteropathogenic Escherichia coli (EPEC) is a subgroup of diarrheagenic E. coli that is responsible for infantile diarrhea worldwide, mostly in developing countries (5). In this study, among 70 EPEC strains, just 2 strains (2.8%) belonged to tEPEC. However, 68 strains (97.1%) classified as aEPEC. These result show high frequency of aEPEC strains among children in Iran. This finding agrees with previous studies which have been demonstrated prevalence of aEPEC in children with or without diarrhea worldwide (16-19). Some aEPEC strains could be tEPEC or EHEC strains that lost BFP-encoding plasmid or stx genes (20). Furthermore, some adhesion encoding genes (lpfA, paa, iha, and toxB) from EHEC have detected in EPEC strains and these genes have been more prevalent in aEPEC than tEPEC (20). Some studies have shown that there are not any relationships between aEPEC and other pathogen types of E. coli (21). On the other hand, a closer relationship was found between aEPEC and EHEC (22). To our knowledge, studies of frequency of antimicrobial resistance in EPEC strains are very rare. High level of antimicrobial resistance have reported in E. coli and other Enterobacteriaceae strains worldwide (7, 9, 23), but in this study the highest rate of antibiotic resistance were shown in 4 strains (5.7%) that were multiple drug resistance. Cefepime showed excellent antimicrobial activity against EPEC strains with 100% of all isolates susceptible. Of other Cephalosporins, ceftazidime and cefotaxime demonstrated good activity (susceptibility rates of 94.2% and 100%, respectively). These trends are in agreement with previous studies that majority of EPEC isolates have been susceptible to third generation cephalosporins (17, 24, 25) World Health organization has recommended ampicillin and co-trimoxazole as therapeutic options for treatment of severe cases of diarrhea. In this study, 4 (5.7%), and 4 (5.7%) isolates were identified which were unsusceptible to ampicillin and co-trimoxazole, respectively. In a study in Mexico, 38% of aEPEC isolates were resistant to ampicillin and co-trimoxazole but 100%, and 67% of tEPEC were resistant to ampicillin and co-trimoxazole, respectively, (17). In contrast, Aslani et al (26) have reported resistant rates of 59%, and 35% for ampicillin and co-trimoxazole, respectively. Similar to earlier published data (24-26), in current study, the majority of isolates (98.5%) were susceptible to ciprofloxacin. However, one isolates was resistant to ciprofloxacin. Furthermore, this isolate was a multiple drug resistant that was resistant to aztreonam, kanamycin, tetracycline, ampicillin, co-trimoxazole, and ceftazidime. Therefore, it seems that aEPEC are more susceptible to ampicillin, co-trimoxazole and other antimicrobial agents than tEPEC. As EPEC is an important cause of diarrhea in children in developing countries, spread of integrons among these strains could threaten the usefulness of antibiotic therapy in persistent or sever cases of diarrhea. Our results showed the prevalence of class 1 integrons is 31.4% among EPEC strains isolated from children with or without diarrhea. In all of EPEC isolates carrying class 1 integron, the qacEρ1 and sul1 genes were identified. These genes determine resistance to antiseptics, disinfectants and sulfonamides, respectively, (27). The aadA genes were first described in 1985 (28). Some studies have shown the presence of aadA cassettes within class1 integrons that encode aminoglycoside 3’-9-adenylyltransferases that are responsible for streptomycin and spectinomycin resistance. Moreover, earlier study has shown that the aadA gene is highly conserved among STEC (29, 30). Although streptomycin and spectinomycin have not been widely prescribed, aadA gene cassettes within integrons have been reported worldwide recently (12, 29). This confirms the fact that gene cassettes from the insert region of integrons are excised as covalently closed circles (31). The cassettes with dfrA gene represented 100% of all EPEC strains that class 1 integrons found in them. dfr gene, which codes for dihydrofolate reductase, confer resistance to trimethoprim that it used largely to treat several infections caused by E. coli in Iran and other developing countries. Therefore, these cassettes are able to become more prevalent. Previously, the role of these gene cassettes in resistance to trimethoprim have been mentioned clearly (12). dfrA12, orfF, and aadA2 cassettes have become globally disseminated (30,32). This cassette confers resistance to trimethoprim, streptomycin, and spectinomycin. Interestingly, these cassettes have detected in variety of gram negative bacteria such as E. coli, Salmonella and Seratia marcesens (29, 32). Our present study showed high frequency of gene cassettes carrying dfrA gene among EPEC strains. In previous studies in Iran, the most prevalent gene cassettes among Salmonella enteritidis and Pseudomonas aeruginosa isolates were aadA6-orfD (33, 34). It is important to focus on these findings that all of multiple drug resistance of EPEC strains in this study demonstrated the presence of integrons carrying antimicrobial resistance gene cassettes. Furthermore, these strains showed resistant to kanamycin and tetracycline that are prescribed to treatment of drug resistant diarrhea. The combination of these findings shows an increasing problem in EPEC strains. Due to antibiotic selective pressures, these resistant EPEC strains could become predominant and colonize easily the gastrointestinal tracts of children. Low level of antibiotic resistance among EPEC strains in this study in compare to detected gene cassettes in class 1 integrons may be due to their gene expression. Overall, these results indicate the widespread distribution of class 1 integrons containing gene cassettes conferring resistance to trimethoprim, streptomycin, and spectinomycin among EPEC strains. These gene cassettes are potentially capable of transmitting resistance determinants to other EPEC strains or to other types of E.coli. Moreover, bacterial strains bearing integrons might become resistant to third generation cephalosporins (35). This transmission of resistant is a serious threat to containment of infectious diseases caused by E. coli.
  35 in total

1.  Characterization of class I integrons among Salmonella enterica serovar Enteritidis isolated from humans and poultry.

Authors:  Farzaneh Firoozeh; Taghi Zahraei-Salehi; Fereshteh Shahcheraghi; Vahid Karimi; Mohammad M Aslani
Journal:  FEMS Immunol Med Microbiol       Date:  2011-11-23

2.  Recombination between the dfrA12-orfF-aadA2 cassette array and an aadA1 gene cassette creates a hybrid cassette, aadA8b.

Authors:  Alicia M Gestal; H W Stokes; Sally R Partridge; Ruth M Hall
Journal:  Antimicrob Agents Chemother       Date:  2005-11       Impact factor: 5.191

3.  Identification of enteropathogenic Escherichia coli by PCR-based detection of the bundle-forming pilus gene.

Authors:  S T Gunzburg; N G Tornieporth; L W Riley
Journal:  J Clin Microbiol       Date:  1995-05       Impact factor: 5.948

Review 4.  Enteropathogenic escherichia coli infection in children.

Authors:  Theresa J Ochoa; Carmen A Contreras
Journal:  Curr Opin Infect Dis       Date:  2011-10       Impact factor: 4.915

5.  Adhesin-encoding genes from shiga toxin-producing Escherichia coli are more prevalent in atypical than in typical enteropathogenic E. coli.

Authors:  Tânia A T Gomes; Rodrigo T Hernandes; Alfredo G Torres; Fábia A Salvador; Beatriz E C Guth; Tânia M I Vaz; Kinue Irino; Rosa M Silva; Mônica A M Vieira
Journal:  J Clin Microbiol       Date:  2011-07-27       Impact factor: 5.948

6.  A nosocomial outbreak of Pseudomonas aeruginosa isolates expressing the extended-spectrum beta-lactamase GES-2 in South Africa.

Authors:  Laurent Poirel; Gerhard F Weldhagen; Christophe De Champs; Patrice Nordmann
Journal:  J Antimicrob Chemother       Date:  2002-03       Impact factor: 5.790

7.  Antibiotic resistance in diarrheagenic Escherichia coli and Shigella strains isolated from children in Hanoi, Vietnam.

Authors:  Trung Vu Nguyen; Phung Van Le; Chinh Huy Le; Andrej Weintraub
Journal:  Antimicrob Agents Chemother       Date:  2005-02       Impact factor: 5.191

8.  Characterisation of atypical enteropathogenic E. coli strains of clinical origin.

Authors:  Sharon M Tennant; Marija Tauschek; Kristy Azzopardi; Andrea Bigham; Vicki Bennett-Wood; Elizabeth L Hartland; Weihong Qi; Thomas S Whittam; Roy M Robins-Browne
Journal:  BMC Microbiol       Date:  2009-06-03       Impact factor: 3.605

9.  Molecular characterization of class 1 integrons in MDR Pseudomonas aeruginosa isolated from clinical settings in Iran, Tehran.

Authors:  Fereshteh Shahcheraghi; Farzad Badmasti; Mohammad M Feizabadi
Journal:  FEMS Immunol Med Microbiol       Date:  2009-11-24

10.  Drug-resistant diarrheogenic Escherichia coli, Mexico.

Authors:  Teresa Estrada-García; Jorge F Cerna; Leova Paheco-Gil; Raúl F Velázquez; Theresa J Ochoa; Javier Torres; Herbert L DuPont
Journal:  Emerg Infect Dis       Date:  2005-08       Impact factor: 6.883

View more
  4 in total

Review 1.  Escherichia coli in Iran: An Overview of Antibiotic Resistance: A Review Article.

Authors:  Hesam Alizade
Journal:  Iran J Public Health       Date:  2018-01       Impact factor: 1.429

2.  Gene cassettes of class I integron-associated with antimicrobial resistance in isolates of Citrobacter spp. with multidrug resistance.

Authors:  Roya Chegene Lorestani; Alisha Akya; Azam Elahi; Yazdan Hamzavi
Journal:  Iran J Microbiol       Date:  2018-02

3.  Molecular characterization of class 1, 2 and 3 integrons in clinical multi-drug resistant Klebsiella pneumoniae isolates.

Authors:  Farzaneh Firoozeh; Zeinab Mahluji; Ahmad Khorshidi; Mohammad Zibaei
Journal:  Antimicrob Resist Infect Control       Date:  2019-03-29       Impact factor: 4.887

4.  The commensal infant gut meta-mobilome as a potential reservoir for persistent multidrug resistance integrons.

Authors:  Anuradha Ravi; Ekaterina Avershina; Steven L Foley; Jane Ludvigsen; Ola Storrø; Torbjørn Øien; Roar Johnsen; Anne L McCartney; Trine M L'Abée-Lund; Knut Rudi
Journal:  Sci Rep       Date:  2015-10-28       Impact factor: 4.379

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.